|
AKTX Akari Therapeutics PLC 1541157 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-4,807,000.00 |
| Balance Sheet |
|
Current Assets
|
$8,324,000.00 |
|
Assets
|
$38,624,000.00 |
|
Current Liabilities
|
$13,935,000.00 |
|
Liabilities
|
$20,029,000.00 |
|
Equity
|
$18,595,000.00 |
|
Shares Out
|
140032769533.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,597,000.00 |
|
Investing Cash Flow
|
$382,000.00 |
| Market Analysis |
Market Cap
|
$1,090,855,274,662.07 |
|
Price
|
$7.79 |
|
PB
|
0.96 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:58 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AKTX documents filed with the SEC.
AKTX Filings
Clear
